Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Neoplasms 3Myelodysplastic Syndromes 3Graft vs Host Disease 3Leukemia, Myeloid, Acute 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Multiple Myeloma 1Lymphoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia 1Hodgkin Disease 1Hematologic Neoplasms 1Anemia, Refractory 1

Interventions

fludarabine phosphate 25Cyclophosphamide 25Busulfan 24Peripheral Blood Stem Cell Transplantation 20Tacrolimus 19Antilymphocyte Serum 19Methotrexate 16Radiotherapy 15Mycophenolic Acid 15Cyclosporine 14Methylprednisolone 12Filgrastim 11Whole-Body Irradiation 10Melphalan 10Etoposide 9Cord Blood Stem Cell Transplantation 9sargramostim 6Cytarabine 6Thalidomide 4Sirolimus 4Alemtuzumab 4thymoglobulin 3Thiotepa 3Granulocyte Colony-Stimulating Factor 3Carmustine 3Carboplatin 3ruxolitinib 2merphos 2gamma-Globulins 2Topotecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative × Abatacept × Clear all
NCT07238712 2025-11-20

APTBCy

St. Petersburg State Pavlov Medical University

Phase 2 Recruiting
60 enrolled
MyeloidOther hematologic neoplasm

Graft vs Host Disease, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡